<info type="DiseaseOrPhenotypicFeature">hypoxic-ischemic neuronal injury</info>.

Developing brain is highly susceptible to <info type="DiseaseOrPhenotypicFeature">hypoxic-ischemic (HI) injury</info> leading to severe <info type="DiseaseOrPhenotypicFeature">neurological disabilities</info> in surviving infants and children. Previously, we have reported induction of <info type="GeneOrGeneProduct">neuronal pentraxin 1 (NP1)</info>, a novel <info type="GeneOrGeneProduct">neuronal protein</info> of long-pentraxin family, following <info type="DiseaseOrPhenotypicFeature">HI neuronal injury</info>. Here, we investigated how this specific signal is propagated to cause the <info type="DiseaseOrPhenotypicFeature">HI neuronal death</info>. We used <info type="OrganismTaxon">wild-type (WT)</info> and <info type="GeneOrGeneProduct">NP1 knockout (NP1-KO)</info> <info type="OrganismTaxon">mouse</info> hippocampal cultures, modeled in vitro following exposure to <info type="ChemicalEntity">oxygen glucose deprivation (OGD)</info>, and in vivo <info type="OrganismTaxon">neonatal (P9-10)</info> <info type="OrganismTaxon">mouse model</info> of <info type="DiseaseOrPhenotypicFeature">HI brain injury</info>. Our results show induction of <info type="GeneOrGeneProduct">NP1</info> in primary hippocampal neurons following <info type="ChemicalEntity">OGD exposure</info> (4-8 h) and in the ipsilateral hippocampal <info type="CellLine">CA1</info> and <info type="CellLine">CA3</info> regions at 24-48 h post-<info type="DiseaseOrPhenotypicFeature">HI</info> compared to the contralateral side. We also found increased <info type="GeneOrGeneProduct">PTEN</info> activity concurrent with <info type="ChemicalEntity">OGD time-dependent</info> (4-8 h) dephosphorylation of <info type="GeneOrGeneProduct">Akt (Ser473)</info> and <info type="GeneOrGeneProduct">GSK-3b (Ser9)</info>. <info type="ChemicalEntity">OGD</info> also caused a time-dependent decrease in the phosphorylation of <info type="GeneOrGeneProduct">Bad (Ser136)</info>, and <info type="GeneOrGeneProduct">Bax</info> protein levels. Immunofluorescence staining and subcellular fractionation analyses revealed increased mitochondrial translocation of <info type="GeneOrGeneProduct">Bad</info> and <info type="GeneOrGeneProduct">Bax</info> proteins from cytoplasm following <info type="ChemicalEntity">OGD (4 h)</info> and simultaneously increased release of <info type="GeneOrGeneProduct">Cyt C</info> from mitochondria followed by activation of <info type="GeneOrGeneProduct">caspase-3</info>. <info type="GeneOrGeneProduct">NP1</info> protein was immunoprecipitated with <info type="GeneOrGeneProduct">Bad</info> and <info type="GeneOrGeneProduct">Bax</info> proteins; <info type="ChemicalEntity">OGD</info> caused increased interactions of <info type="GeneOrGeneProduct">NP1</info> with <info type="GeneOrGeneProduct">Bad</info> and <info type="GeneOrGeneProduct">Bax</info>, thereby, facilitating their mitochondrial translocation and dissipation of mitochondrial membrane potential (<info type="ChemicalEntity">D (m)</info>). This <info type="GeneOrGeneProduct">NP1</info> induction preceded the increased mitochondrial release of <info type="GeneOrGeneProduct">cytochrome C (Cyt C)</info> into the cytosol, activation of <info type="GeneOrGeneProduct">caspase-3</info> and <info type="ChemicalEntity">OGD time-dependent cell death</info> in <info type="OrganismTaxon">WT primary hippocampal neurons</info>. In contrast, in <info type="GeneOrGeneProduct">NP1-KO neurons</info> there was no translocation of <info type="GeneOrGeneProduct">Bad</info> and <info type="GeneOrGeneProduct">Bax</info> from cytosol to the mitochondria, and no evidence of <info type="ChemicalEntity">D (m)</info> loss, increased <info type="GeneOrGeneProduct">Cyt C</info> release and <info type="GeneOrGeneProduct">caspase-3</info> activation following <info type="ChemicalEntity">OGD</info>; which resulted in significantly reduced <info type="DiseaseOrPhenotypicFeature">neuronal death</info>. Our results indicate a regulatory role of <info type="GeneOrGeneProduct">NP1</info> in <info type="GeneOrGeneProduct">Bad/Bax</info>-dependent mitochondrial release of <info type="GeneOrGeneProduct">Cyt C</info> and <info type="GeneOrGeneProduct">caspase-3</info> activation. Together our findings demonstrate a novel mechanism by which <info type="GeneOrGeneProduct">NP1</info> regulates mitochondria-driven <info type="DiseaseOrPhenotypicFeature">hippocampal cell death</info>; suggesting <info type="GeneOrGeneProduct">NP1</info> as a potential therapeutic target against <info type="DiseaseOrPhenotypicFeature">HI brain injury</info> in <info type="OrganismTaxon">neonates</info>.